Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

s decreased 18% to $14.3 million in 2012 from $17.4 million in 2011.  In 2012 we experienced lower research and development costs than in the prior year due primarily to decreased manufacturing costs in the hearing and FMD programs, the closeout of the PACT trial, reduced personnel costs as a result of our reduction in force, reduced material costs for our funded programs, and reduced equipment purchases under our hearing and FMD programs.  These decreases were partially offset by increased outside costs for our other research programs as compared to 2011.

General and administrative expenses increased 17% to $9.1 million in 2012 from $7.8 million in 2011.  General and administrative expenses were higher in 2012 primarily due to personnel costs, which included approximately $1.3 million in non-recurring employment costs.

Fourth Quarter 2012 ResultsFor the fourth quarter ended December 31, 2012, GenVec reported a net loss of $3.2 million, or $0.24 per share, compared with a net loss of $2.5 million, or $0.19 per share, for the comparable prior year period.  The Company reported revenues of $1.5 million in the fourth quarter of 2012 compared to $3.4 million for the same period in 2011.  This decrease was primarily due to reduced revenue related to both our hearing loss and balance disorders program, $1.3 million, and FMD program, $0.2 million.  Reduced revenue in each case is due to a reduced work scope in the 2012 period as compared to the same period in 2011.  Research and development expenses decreased 21% in 2012 from $3.9 million in the fourth quarter of 2011 to $3.1 million in the fourth quarter of 2012 due mainly to reduced personnel and manufacturing costs.  General and administrative expenses in the fourth quarter of 2012 decreased 20% to $1.6 million from $2.0 million in the comparable period in 2011 primarily due to decreased personnel and recruiting costs, partially offset by higher professional costs.
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... DUBLIN , Aug. 19, 2014 ... the "Pharmaceutical Contract Manufacturing - Global Strategic Business ... This report analyzes the worldwide markets for Pharmaceutical Contract ... Injectables (Injections, Vials, and IV solutions), Solid Dosage Forms ... (Syrups, Suspensions, Gels, Creams & Ointments). The ...
(Date:8/19/2014)... , Aug. 19, 2014 Research and Markets ... by Type of Material, by Technology, by Application & by ... their offering. The demand for membranes is ... driving the market to $29.31 billion Membrane technology ... applications, such as water filtration and kidney dialysis. In modern ...
(Date:8/19/2014)... According to Kalorama Information, electronic medical records ... Data in healthcare a reality, and this a factor ... American Recovery and Reinvestment Act, the U.S. government dedicated ... penalties will start applying soon for use of paper ... study of the EMR industry, EMR 2014: The ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3
(Date:8/19/2014)... in multitasking and ways to train it have been ... universitaire de griatrie de Montral and the University of ... the effectiveness of this training. Cooking while having a ... driving while listening to a radio show ... Unfortunately, it decreases with age, which makes it harder ...
(Date:8/19/2014)... August 20, 2014 Recently, iFitDress.com,a leading ... outfits, has unveiled its new collection of pewter ... to expand the company’s global market. Each item is ... the company’s senior spokesman, customers that have specific requirements ... iFitDress.com. Now, all the brand new items are offered ...
(Date:8/19/2014)... -- Lupus and other rheumatic diseases can cause ... can delay a correct diagnosis for months, a ... can also cause these types of symptoms, according ... in Maywood, Ill. Rheumatic disorders include autoimmune and ... such as lupus, systemic vasculitis and ankylosing spondylitis. ...
(Date:8/19/2014)... from Glasgow where he helped distribute thousands of The ... 23 – August 6), Pete Dwan is a man with ... for his work cannot be overstated. , According to UK ... A drugs within the last year. And that doesn’t take ... to be “legal highs” until June 2014, when the UK ...
(Date:8/19/2014)... the longtime standard treatment for atrial fibrillation, is ... drug marketplace including dabigatran, rivaroxaban, and apixaban. A ... novel oral anticoagulants (NOACs) into clinical practice. By ... anticoagulant prescriptions yet this represents 98% of total ... The American Journal of Medicine . , Atrial ...
Breaking Medicine News(10 mins):Health News:Targeted brain training may help you multitask better 2Health News:Discounted Pewter Evening Dresses For 2014 Unveiled By Company iFitDress.com 2Health News:Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report 2Health News:British Scientologist on a Mission to Save Youth from Drug Abuse 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 2Health News:Novel oral anticoagulant prescriptions soar, but at a high cost 3
... Oct. 15 Impelsys , a global ... American Academy of Pediatrics (AAP), a ... solidified its e-book strategy with iPublishCentral , ... 350 publishers worldwide. Launching in early 2010, AAP will ...
... DEERFIELD, Ill., October 14, 2009 A study, published ... showed that a greater percentage of patients with type ... (pioglitazone HCl and metformin HCl) as initial therapy reached ... percent compared to either component alone. Safety and tolerability ...
... at reducing the risk of heart attacks and heart ... new report from the Institute of Medicine. The ... secondhand smoke boosts nonsmokers, risk for heart problems, adding ... could lead to a heart attack is compelling. ...
... Program Seeks Adult Athletes to Go the Extra Mile to ... Teen and pre-teen girls face peer pressure, cultural stereotypes ... impact on their futures. That is why former Ironman ... prevention program that prepares girls for a lifetime of self-respect ...
... DIEGO, Oct. 15 Cardium Therapeutics (NYSE Amex: CXM ... to selected investors for aggregate gross proceeds of $6.0 million. ... was filed by Cardium Therapeutics with the Securities and Exchange ... August 15, 2007. Details concerning the terms of the ...
... tradition of capturing celebrity in photograph with 2009 Christmas ... Lung Association has brought back a time-honored tradition this ... a photograph with the 2009 Christmas Seal. This ... distinguished list of celebrities and entertainers who have served ...
Cached Medicine News:Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 2Health News:Leading Society Publisher, American Academy of Pediatrics, Chooses iPublishCentral to Launch e-Book Strategy 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 2Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 3Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 4Health News:New data showed type 2 diabetes patients experienced greater blood sugar reductions 5Health News:Smoking bans reduce the risk of heart attacks associated with secondhand smoke 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 2Health News:Girls on the Run Inspires Girls to Recognize and Achieve Their Potential Through the Power of Running 3Health News:Cardium Announces $6.0 Million Registered Direct Offering 2Health News:Cardium Announces $6.0 Million Registered Direct Offering 3Health News:S. Epatha Merkerson Lends Star Power to Support the American Lung Association's Christmas Seals Campaign as Celebrity Chairperson 2
... / Ker Accuref K 9001 ... LCD color monitor. 3 step ... 2.3 mm Minimum pupil diameter ... adjuster. Auto start function. Kerato-Peripheral ...
... Suresight is the child-friendly, portable ... children and adults. It can perform ... inches (35 cm) away even through ... flashing lights and sounds engage the ...
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: